Cargando…

Protective effects of bifidobacteria against enteropathogens

Recent major advances in metagenomics and metabolomics technologies have enabled us to collect more data on the gut microbiome and metabolome to evaluate its influence on host health. In this short opinion article, we have chosen to focus on summarizing the protective mechanisms of bifidobacteria, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Aw, Wanping, Fukuda, Shinji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801159/
https://www.ncbi.nlm.nih.gov/pubmed/31284329
http://dx.doi.org/10.1111/1751-7915.13460
_version_ 1783460523676794880
author Aw, Wanping
Fukuda, Shinji
author_facet Aw, Wanping
Fukuda, Shinji
author_sort Aw, Wanping
collection PubMed
description Recent major advances in metagenomics and metabolomics technologies have enabled us to collect more data on the gut microbiome and metabolome to evaluate its influence on host health. In this short opinion article, we have chosen to focus on summarizing the protective mechanisms of bifidobacteria, a highly regarded probiotic, and it's metabolite: acetate; against enteropathogens, specifically in the E. coli O157:H7 mice model. We advocate for using a novel approach metabologenomics, which is an integration of metagenomic and metabolomic information on a systems biology‐wide approach to better understand this interplay between gut microbiome and host metabolism.
format Online
Article
Text
id pubmed-6801159
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68011592019-10-22 Protective effects of bifidobacteria against enteropathogens Aw, Wanping Fukuda, Shinji Microb Biotechnol Opinion Recent major advances in metagenomics and metabolomics technologies have enabled us to collect more data on the gut microbiome and metabolome to evaluate its influence on host health. In this short opinion article, we have chosen to focus on summarizing the protective mechanisms of bifidobacteria, a highly regarded probiotic, and it's metabolite: acetate; against enteropathogens, specifically in the E. coli O157:H7 mice model. We advocate for using a novel approach metabologenomics, which is an integration of metagenomic and metabolomic information on a systems biology‐wide approach to better understand this interplay between gut microbiome and host metabolism. John Wiley and Sons Inc. 2019-07-08 /pmc/articles/PMC6801159/ /pubmed/31284329 http://dx.doi.org/10.1111/1751-7915.13460 Text en © 2019 The Authors. Microbial Biotechnology published by John Wiley & Sons Ltd and Society for Applied Microbiology. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Opinion
Aw, Wanping
Fukuda, Shinji
Protective effects of bifidobacteria against enteropathogens
title Protective effects of bifidobacteria against enteropathogens
title_full Protective effects of bifidobacteria against enteropathogens
title_fullStr Protective effects of bifidobacteria against enteropathogens
title_full_unstemmed Protective effects of bifidobacteria against enteropathogens
title_short Protective effects of bifidobacteria against enteropathogens
title_sort protective effects of bifidobacteria against enteropathogens
topic Opinion
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801159/
https://www.ncbi.nlm.nih.gov/pubmed/31284329
http://dx.doi.org/10.1111/1751-7915.13460
work_keys_str_mv AT awwanping protectiveeffectsofbifidobacteriaagainstenteropathogens
AT fukudashinji protectiveeffectsofbifidobacteriaagainstenteropathogens